CMS: Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-Based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements

Notice of final rule from the Centers for Medicare and Medicaid Services (CMS) regarding regulatory changes to support state flexibility to enter into value-based purchasing arrangements (VBPs) with manufacturers. This rule also implements provisions of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act designed to reduce opioid-related fraud, misuse, and abuse through the Medicaid Drug Utilization Review (DUR) program. This rule is effective March 1, 2021.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news